Diabetes Mellitus Type 2, Dyslipidemia and Blood Pressure: Common Pathway to Development of Metabolic Syndrome

Type of this study was single blind, placebo controlled and was approved by ethics committee of the hospital. Okra was used to see hypolipidemic, hyopoglycemic and hypotensive effects in primary and secondary hyperlipidemic patients. Separate folder was made to keep record of Pre and post treatment values of the parameters like blood pressure, total cholesterol, LDL cholesterol, HDL cholesterol, and blood sugar. Pre and post treatment values were compared after therapy, which proved that as compared to placebo, total cholesterol, triglycerides, LDL cholesterol and fasting blood sugar was reduced significantly with p-value <0.001. HDL cholesterol was increased with p-value <0.01 which was significant change. Results of study concluded that okra can reduce lipid profile and fasting blood sugar in primary and secondary hyperlipidemic patients and can be used to prevent metabolic syndrome leading to other health related consequences like heart diseases and central nervous system illnesses.